L
ong-term infections with retroviruses such as HIV and human T cell leukemia virus-I are associated with an increased risk for Kaposi's sarcoma (1, 2) , non-Hodgkin's lymphoma (3, 4) , anogenital cancers (5) , and liver cancer (6) . Although the depletion of HIV-infected CD4 ϩ T cells plays a major role in the immunosuppression associated with AIDS, it has also been shown that immunosuppression occurs before the onset of AIDS, and even before CD4 ϩ T cells become depleted (7) . Little is currently known about the mechanisms of this HIV-induced immunosuppression in vivo.
We have used mice infected with Friend virus (FV) as an experimental model to study in vivo mechanisms of retrovirusinduced immunosuppression (8) . We have been particularly interested in chronic or persistent FV infections because much of the damage caused by human retroviral infections is a result of chronic infection. Chronic infections with FV occur in strains of mice that are able to resolve acute infection by mounting strong virus-specific cytotoxic T lymphocyte (CTL), T helper, and B cell responses (9) . Despite these immune responses, the virus is never completely eradicated, and the mice harbor lifelong but low level persistent infections. Persistent virus is primarily localized in a small fraction of splenic B cells, with very little infection in T cells (10) . No clinical signs have previously been associated with chronic FV infections, and 95% of the animals live a normal lifespan. For unknown reasons, the remaining 5% relapse with FV-induced erythroleukemia (11) .
Studies have shown that CD4 ϩ T cells are critical for the long-term control of persistent FV infections. Mice that are experimentally depleted of CD4 ϩ T cells reactivate FV and progress to erythroleukemia (10) . One mechanism of CD4 ϩ T cell-mediated control of persistent FV is the production of IFN-␥, which has both direct and indirect antiviral activities (12) . The current studies further probe the role of CD4 ϩ T cells in chronic FV infection. Paradoxically, we found that CD4 ϩ T cells in chronically infected mice were associated not only with protection from relapse of FV-induced erythroleukemia but also with a previously unknown form of FV-induced immunosuppression. Viruses and Virus Infection. The FV stock was a complex of B-tropic Friend murine leukemia helper virus and polycythemiainducing spleen focus-forming virus (13) . Chronically infected mice were mice that had been rested for 2 months after i.v. infection with 1,500 spleen focus-forming units of virus.
Materials and Methods
Cell Lines. FBL-3 is an FV-induced tumor line from the C57BL͞6 (B6) mouse (14) . E(G2 is an AKV͞Gross' virus-induced tumor cell line from a B6 mouse (15) . EL4 is a dimethylbenzanthracene-induced tumor cell line from a B6 mouse (16) . EL4͞HER2 is an EL4 cell clone transfected with the human oncogene HER2͞NEU from SY-BR-3, a human breast-cancer cell line (American Type Culture Collection). P815 is a chemically induced mastocytoma from a DBA͞2 mouse (17) . LB27.4 is an H-2 b/d class II 
Results
Although it has been shown that infection with FV caused suppression of various host immune responses, immunosuppression was demonstrated only during the acute phase of infection and was restricted to mice that were highly susceptible to FV-induced erythroleukemia (25) (26) (27) . To determine whether mice harboring chronic FV infections were also immunosuppressed, they were challenged with antigenic tumor transplants. Three types of rejectable mouse-cell tumors were studied: (i) E(G2, a tumor induced by AKV, a murine leukemia virus that is antigenically distinct from Friend murine leukemia virus; (ii) EL4͞HER2, a chemically induced tumor expressing the HER2 human oncogene; and (iii) FBL-3, a Friend murine leukemia virus-induced tumor that expressed FV antigens but did not produce live virus. When naive mice were transplanted with E(G2, the tumors were rejected within 4 weeks (Fig. 1) . Interestingly, only two of nine mice chronically infected with FV were able to reject these same tumors. There was not a complete loss of antitumor immunity, as most chronically infected mice were still able to reject EL4͞HER2 tumors. Unexpectedly, the suppression of anti-tumor responsiveness extended to FVinduced FBL-3 tumors. Because FBL-3 expresses numerous FV antigens (28, 29) and can be used to immunize mice against acute FV-induced disease, we expected an anamnestic response rather than a suppressed one. The rejection of FBL-3 tumors is mediated predominantly by CD8 ϩ T cells (14) , so the results suggested that the CD8 ϩ T cell response in these mice was suppressed.
To establish an in vitro method to analyze the immunosuppression of chronically infected mice further, allogeneic MLCs were tested for the generation of CTL responses. MLCs using T cells purified from chronically infected mice consistently generated 20-30% less cytolysis than uninfected mice, representing a 4-fold decrease in lytic units ( Fig. 2A) . The targets in this assay expressed MHC class I, but not class II, molecules, indicating that the generation of class I restricted CTL activity was suppressed. Furthermore, the suppression of allogeneic reactivity in MLCs demonstrated a broad immunosuppression not confined to FV-specific antigens.
To examine more thoroughly whether suppression was confined to MHC class I restricted CD8 ϩ T cells, MLCs using purified CD8 ϩ or CD4 ϩ T cells were tested for cytolytic activity against targets that expressed only MHC class I molecules or both class I and class II molecules, respectively. Surprisingly, when purified CD8 ϩ T cells were used for the MLCs, high cytotoxic reactivity was obtained from infected mice as well as uninfected mice (Fig. 2B ). However, when purified CD4 ϩ T cells from infected mice were used for the MLCs, significantly less cytotoxic reactivity developed than when CD4 ϩ T cells from uninfected mice were used (Fig. 2C) . Thus, in contrast to the results with whole T cells, the data from purified T cell subsets indicated that suppression was isolated to the CD4 ϩ T cell compartment. One explanation that could reconcile these results is that the CD4 ϩ T cells from chronically infected mice were suppressing the generation of CD8 ϩ CTLs when the T cell populations were mixed. To test this hypothesis, MLCs were set up by using mixed or matched CD4 ϩ and CD8 (Fig. 2 D and E) . In contrast, there was no inhibition by CD4 ϩ T cells from uninfected mice. Thus, FV infection had induced or expanded a population of inhibitory CD4 ϩ T cells that could suppress the generation of both CD8 (Fig. 3 Left) . In contrast, all mice adoptively transferred with CD4 ϩ T cells failed to reject FBL-3 tumors (Fig. 3 Right) .
Flow cytometry was used to determine whether chronically infected mice had altered subpopulations of CD4 ϩ T cells expressing CD25 or CD38, cell surface molecules associated with regulatory cells (30, 31) . We also analyzed the CD69 early activation marker because previously we had found significantly increased levels of CD4 ϩ CD69 ϩ cells in chronically infected mice. The subset of CD4 ϩ T cells expressing CD38 and the subset expressing CD69 were increased in chronically infected mice, as was the subpopulation that stained positive for both these markers (Table 1 ). In addition, the subpopulation of CD25 ϩ cells coexpressing CD69 was also increased in the chronically infected mice. In terms of real cell numbers rather than percentages, the persistently infected mice never fully recover from the FVinduced splenomegaly that occurs during acute infection, and their spleens contain an average of twice as many cells as naive mice Bold indicates statistically significant differences between infected and uninfected mice. n ϭ 4 for both infected and uninfected groups.
The high expression levels of CD69 on the CD4 ϩ T cells allowed us to use this marker to do an immunomagnetic bead purification and test whether this subset could suppress the generation of CD8 ϩ CTLs in allogeneic MLCs. Interestingly, the CD4 ϩ CD69 ϩ cells from both infected and uninfected mice showed similar dose-dependent suppressive effects (Fig. 4A) . In contrast, the CD4 ϩ CD69 Ϫ cells were not suppressive. Thus, CD69 marked a subpopulation of splenic CD4 ϩ T cells that were enriched for immunosuppressive activity regardless of FV infection. The reason for the difference between infected and uninfected mice when using total CD4 ϩ cells seems to be the quantitative increase in the subpopulation of CD4 ϩ CD69 ϩ regulatory cells in the infected mice.
To analyze possible mechanisms of CD4 ϩ CD69 ϩ T cellmediated suppression, we added antibodies to the MLC to block previously described mediators of suppression: transforming growth factor-␤ (TGF-␤), a cytokine with potent immunosuppressive capacity; IL-10R, the receptor for the immunosuppressive cytokine, interleukin 10 (32-34); and CTLA-4 (CD152), a cell surface molecule that transduces suppressive regulatory signals (21, 35, 36) . The CD4 ϩ CD69 ϩ T cell-mediated suppression of allogeneic CTL generation was partially reversed by the addition of anti-CD152 mAb or anti-TGF-␤ mAb (Fig. 4B) . Furthermore, an additive effect was obtained when both CD152 and TGF-␤ were blocked; anti-IL-10 receptor mAb did not block. Flow cytometric analysis of the cultures showed that the CD8 ϩ cells did not undergo blast cell formation when CD4 ϩ CD69 
Discussion
These results demonstrate a mechanism of virus-induced immunosuppression by means of the generation or expansion of CD4 ϩ regulatory T cells. Such cells compose a normal subset of cells that actively suppress immune responses directed against self antigens (30, 37) . Suppressive activity by regulatory T cells has been well documented by experiments in which adoptive transfers of these cells have protected mice and͞or rats against experimental autoimmune encephalitis (23, 38, 39), autoimmune colitis (32, 33) , and autoimmune diabetes (40) (41) (42) (43) (44) . There is also extensive evidence that regulatory T cells can mediate tolerance to transplantation with foreign tissues (45) . However, our study provides clear evidence that an overabundance of CD4 ϩ regulatory cells can lead to immunosuppression.
The transfer of suppression to uninfected mice by adoptive transfers of CD4 ϩ T cells obtained from chronically infected mice (Fig. 3) is reminiscent of studies showing that T cells could transfer tolerance from one animal to another in a process termed ''infectious tolerance'' (46) . We also found that FBL-3 tumor rejection in chronically infected mice could be partially restored by in vivo depletions of CD4 ϩ T cells (data not shown). It makes little sense to improve immune responsiveness by depleting CD4 ϩ T cells unless that population contains cells with suppressor activity. Because FBL-3 tumor rejection in vivo is mediated by CD8 ϩ T cells (14) , it seems that the CD4 ϩ regulatory cells act on CD8 ϩ T cells to inhibit their function. We found a similar situation in vitro where CD4 ϩ regulatory T cells acted to reduce generation of CD8 ϩ CTLs in MLCs. Furthermore, the subset of CD4 ϩ T cells that coexpressed CD69 and that was increased in the chronically infected mice was immunosuppressive in vitro. Taken as a whole, the results provide strong evidence that CD4 ϩ regulatory T cells mediate the immunosuppression of chronically infected mice. Several different mechanisms of suppression by CD4 ϩ T cells have been described, including TGF-␤ secretion stimulated by cell-to-cell signaling through CD152 (CTLA-4; refs. [47] [48] [49] . Our antibody blocking data are consistent with such a mechanism; in contrast, we found no evidence of involvement for IL-10 (33, 50, 51).
CD69 has been described as an early marker of activation on lymphocytes (52) , but our data show that it is also expressed on many CD4 ϩ regulatory cells as well. We do not propose that CD69 is a specific marker for CD4 ϩ regulatory cells, but rather 1 effector-to-target ratio at the specific lysis of 92.7%. Error bars were determined from triplicate wells of a single assay. Similar results were obtained from this experiment at the 10:1 effector-to-target ratio and also from multiple target-to-effector ratios in an independent experiment. CD4 ϩ T cells from spleens of the infected mice in this assay were 31.8% CD69 ϩ , whereas the CD4 ϩ T cells from spleens of the uninfected mice were 17.5% CD69 ϩ . The purity of all purified T cell subsets was greater than 92%. (B) Blocking of CD4 ϩ CD69 ϩ cell-mediated suppression with mAbs. Anti-CD152 mAb, anti-TGF-␤ mAb, or anti-IL-10 (IL10R) receptor mAb were added to MLC containing CD8 ϩ T cells from uninfected mice and 3 ϫ 10 5 CD4 ϩ CD69 ϩ cells from chronically infected (B10 ϫ A.BY)F 1 mice. The same concentrations of control antibodies were added as indicated. Cultured MLC cells were harvested and tested for cytotoxicity against P815 cells, and the percentage of suppression of specific lysis was calculated for the 40:1 effector-to-target ratio. Error bars were determined from triplicate wells of cytotoxic assay; similar results were obtained from the 10:1 effector-to-target ratio as well as from an independent experiment.
that CD4 ϩ regulatory cells can be enriched by sorting them on the basis of CD69 expression. Interestingly, both CD25, the cell surface marker most commonly associated with immunoregulatory cells, and CD38, another marker described on immunoregulatory cells, are described also as activation markers (31, 53, 54) . Presently, it is unclear why molecules associated with activation also are associated with suppression. However, once specifically activated, CD4 ϩ regulatory T cells have been demonstrated to suppress immune responses in a nonspecific manner (41, 55) , which may possibly explain the broad nature of the immunosuppression in our studies.
It will be of great interest to determine whether specific viral gene products, such as the highly conserved immunosuppressive peptide found in the envelope protein of many retroviruses (56) , are responsible for generating regulatory T cells, or whether it is simply the persistence of the infection that induces peripheral tolerance. Also, it will be interesting to determine whether these findings have any relevance to human retroviral infections. In that regard, it has been shown that patients with HIV have a significant increase in CD4 ϩ T cells expressing CD38 (57-59), but those cells have been considered ''activated,'' and their possible role in immunosuppression has not been studied. Interestingly, another cell surface marker on CD4 ϩ T cells that is up-regulated in patients with HIV is a molecule known as regeneration and tolerance factor (RTF; ref. 60) . Although cells expressing RTF also have been considered activated, the association between RTF and the generation of peripheral tolerance (61, 62) suggests that CD4 ϩ T cells expressing RTF may be involved in immunosuppression. It is possible that the ability of HIV and human T cell leukemia virus-I to escape immunological destruction and establish persistent infections is related to their ability to suppress the immune system through the generation of CD4 ϩ regulatory cells. If human retrovirus-induced immunosuppression is even partly caused by regulatory cells, then this aspect of the disease may be amenable to treatment with immunomodulatory therapies.
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